Alcon IQ approved in US

Article

The aspheric AcrySof IQ Toric intraocular lens (Alcon Inc) has been approved by the FDA, and will shortly be available to provide improved distance vision to patients with cataract and astigmatism.

The aspheric AcrySof IQ Toric intraocular lens (Alcon Inc) has been approved by the FDA, and will shortly be available to provide improved distance vision to patients with cataract and astigmatism.

The AcrySof Toric was initially introduced in 2005. Its acrylic single-piece design provided good rotational stability in addition to the more accurate prediction of power outcomes the lens made possible. The aspheric optic of the new lens will allow for increased contrast sensitivity, and its thinner profile makes it suitable for micro-coaxial surgical techniques.

Alcon plans to launch the AcrySof IQ Toric at the 2009 meeting of the American Society of Cataract and Refractive Surgeons (ASCRS), which will be held in San Francisco, California from April 3–8.

Related Videos
Fritz Hengerer, MD, PhD, Director, Eye Hospital at Bürgerhospital, Frankfurt, Germany
Dr Sheng Lim, professor of glaucoma studies at St Thomas' Hospital, London
Kasperi Kankare at the iCare booth at ESCRS
Scott D Barnes, MD, CMO of STAAR Surgical
Tomislav Bucalic, head of marketing at Geuder, and David Geuder, member of the executive board and CIO
Colman Cawe, director of fundraising and communications, Orbis UK
Greg Kunst, CEO of Aurion Biotech
Related Content
© 2023 MJH Life Sciences

All rights reserved.